Delivery Order SPE2DR25D2014-SPE2DR26FZ74Y
Award Date 11/18/25
Potential Completion Date 11/19/25
Potential Value $2.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $11,868.90 to AmerisourceBergen Drug Corp for the supply of HUMIRA (Adalimumab) 40 mg/0.4 mL pen injectors. The contract is a firm fixed-price delivery order with no set-aside designation, issued on April 24, 2025, with an ultimate completion date of April 25, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the...
- The Defense Logistics Agency awarded a $2,265.90 delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of HUMIRA (Adalimumab) pen injectors at a strength of 40 mg/0.4 mL. This competitive award, which has no set-aside designation, represents a firm fixed-price delivery order with an ultimate completion date of November 3, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of HUMIRA (adalimumab) 40 mg/0.4 mL pen injections, valued at $46,099.45. This competitively awarded, non-set-aside contract is structured as a firm fixed price delivery order with an ultimate completion date of June 23, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $41,000 to AmerisourceBergen Drug Corp for the supply of HUMIRA (Adalimumab) pen injections, 40 mg/0.4 mL. This non-competitive, firm fixed-price delivery order was issued on October 20, 2025, with an ultimate completion date of October 21, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $3,715.82 delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of HUMIRA (Adalimumab) CF Pen 40 mg/0.4 mL. This competitively awarded, firm fixed-price contract is set to conclude on October 28, 2025, with performance executed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger pharmaceutical supply relationship with the...
- The Defense Logistics Agency awarded a $3,700.03 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of HUMIRA (adalimumab) CF Pen 40 mg/0.4 mL. The contract, with an ultimate completion date of November 7, 2025, represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. This award involved no set-aside designation and was competitively awarded. AmerisourceBergen, a major...
- The Defense Logistics Agency awarded a delivery order valued at $3,183.92 to AmerisourceBergen Drug Corp for the supply of HUMIRA (Adalimumab) Pen 40 mg/0.4 mL on November 14, 2025, with an ultimate completion date of November 17, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The pharmaceutical will be sourced from the vendor's Conshohocken, Pennsylvania location, which serves as the company's corporate headquarters...
- The Defense Logistics Agency awarded a $13,075.97 delivery order to AmerisourceBergen Drug Corp for HUMIRA (Adalimumab) prefilled pens, 40 mg/0.4 mL dosage. This contract is a firm fixed price delivery order with an ultimate completion date of August 5, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters location. This delivery order is issued under...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of HUMIRA (adalimumab) Pen 40 mg/0.4 mL, a biologic immunosuppressant medication. This firm fixed-price delivery order, valued at $57,804.94, represents a non-competitive award under a larger contract vehicle and is scheduled for completion by August 8, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $2,324.75 firm fixed price delivery order to AmerisourceBergen Drug Corp for HUMIRA (adalimumab) CF pen 40 mg/0.4 mL on November 14, 2025, with completion targeted for November 17, 2025. This is an unset-aside, competitively awarded contract with place of performance in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...